Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia

We report the long‐term outcome results of 57 consecutive adult patients with immune thrombocytopenia after being treated with rituximab. According to the different period of therapy, patients received either standard dose (SD) rituximab (i.e., 375 mg/m2 weekly for 4 weeks) or low dose (LD) rituxima...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2012-09, Vol.87 (9), p.886-889
Hauptverfasser:	Zaja, Francesco, Volpetti, Stefano, Chiozzotto, Marianna, Puglisi, Simona, Isola, Miriam, Buttignol, Silvia, Fanin, Renato
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - administration & dosage Antibodies, Monoclonal, Murine-Derived - adverse effects Antibodies, Monoclonal, Murine-Derived - therapeutic use Biological and medical sciences Disease-Free Survival Dose-Response Relationship, Drug Drug Administration Schedule Follow-Up Studies Hematologic and hematopoietic diseases Hematology Humans Immunologic Factors - administration & dosage Immunologic Factors - adverse effects Immunologic Factors - therapeutic use Medical sciences Middle Aged Platelet Count Platelet diseases and coagulopathies Purpura, Thrombocytopenic, Idiopathic - blood Purpura, Thrombocytopenic, Idiopathic - drug therapy Purpura, Thrombocytopenic, Idiopathic - mortality Purpura, Thrombocytopenic, Idiopathic - surgery Recurrence Rituximab Salvage Therapy - methods Splenectomy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!